Sciencebiotech
Cholesterol-linked drug boosts gene-targeting potency in early findings
Nucleic acid therapeutics like antisense oligonucleotides have emerged as promising platforms for treating various previously hard-to-treat diseases, including neurological conditions. Recent early findings indicate that linking these therapies to cholesterol can significantly enhance their gene-targeting potency and delivery efficiency.